Javed Butler

117.9k total citations · 35 hit papers
825 papers, 42.1k citations indexed

About

Javed Butler is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Javed Butler has authored 825 papers receiving a total of 42.1k indexed citations (citations by other indexed papers that have themselves been cited), including 625 papers in Cardiology and Cardiovascular Medicine, 219 papers in Endocrinology, Diabetes and Metabolism and 133 papers in Surgery. Recurrent topics in Javed Butler's work include Heart Failure Treatment and Management (458 papers), Cardiovascular Function and Risk Factors (272 papers) and Diabetes Treatment and Management (194 papers). Javed Butler is often cited by papers focused on Heart Failure Treatment and Management (458 papers), Cardiovascular Function and Risk Factors (272 papers) and Diabetes Treatment and Management (194 papers). Javed Butler collaborates with scholars based in United States, Germany and United Kingdom. Javed Butler's co-authors include Gregg C. Fonarow, Gerasimos Filippatos, Clyde W. Yancy, Stephen J. Greene, Muthiah Vaduganathan, Lynne W. Stevenson, Stefan D. Anker, Frederick A. Masoudi, Mariell Jessup and Paul A. Heidenreich and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Javed Butler

769 papers receiving 41.0k citations

Hit Papers

2017 ACC/AHA/HFSA Focused... 2004 2026 2011 2018 2017 2011 2017 2013 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
    2017 2.8k citations Javed Butler, Gerasimos Filippatos et al. Journal of the American College of Cardiology profile →
  2. Forecasting the Future of Cardiovascular Disease in the United States
    2011 2.4k citations Paul A. Heidenreich, Justin G. Trogdon et al. Circulation profile →
  3. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
    2017 2.1k citations Javed Butler, Gerasimos Filippatos et al. Circulation profile →
  4. Forecasting the Impact of Heart Failure in the United States
    2013 2.1k citations Paul A. Heidenreich, Nancy M. Albert et al. Circulation Heart Failure profile →
  5. The Global Health and Economic Burden of Hospitalizations for Heart Failure
    2014 1.5k citations Gregg C. Fonarow, Javed Butler et al. Journal of the American College of Cardiology profile →
  6. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    2020 831 citations Faı̈ez Zannad, João Pedro Ferreira et al. profile →
  7. Medical Therapy for Heart Failure With Reduced Ejection Fraction
    2018 760 citations Stephen J. Greene, Javed Butler et al. Journal of the American College of Cardiology profile →
  8. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
    2004 706 citations Javed Butler, Christopher M. O’Connor et al. Journal of the American College of Cardiology profile →
  9. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
    2021 575 citations Thomas M. Maddox, James L. Januzzi et al. Journal of the American College of Cardiology profile →
  10. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
    2017 575 citations Javed Butler, Gerasimos Filippatos et al. profile →
  11. Myocardial Interstitial Fibrosis in Heart Failure
    2018 467 citations Javed Butler et al. Journal of the American College of Cardiology profile →
  12. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
    2016 454 citations Javed Butler, Gerasimos Filippatos et al. Journal of the American College of Cardiology profile →
  13. Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
    2019 413 citations James L. Januzzi, Javed Butler et al. profile →
  14. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
    2017 323 citations Gregory D. Lewis, Adrian F. Hernandez et al. profile →
  15. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
    2019 303 citations Stephen J. Greene, Gregg C. Fonarow et al. Journal of the American College of Cardiology profile →
  16. Empagliflozin in Heart Failure
    2020 270 citations Javed Butler et al. Circulation profile →
  17. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction
    2020 266 citations Milton Packer, Stefan D. Anker et al. Circulation profile →
  18. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
    2020 243 citations Stefan D. Anker, Javed Butler et al. Circulation profile →
  19. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
    2021 226 citations Milton Packer, Javed Butler et al. Circulation profile →
  20. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
    2022 158 citations Javed Butler, Mikhail Kosiborod et al. profile →
  21. Trends in 30- and 90-Day Readmission Rates for Heart Failure
    2021 156 citations Muhammad Shahzeb Khan, Stephen J. Greene et al. Circulation Heart Failure profile →
  22. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
    2024 123 citations Mikhail Kosiborod, Barry A. Borlaug et al. profile →
  23. Ferric Carboxymaltose in Heart Failure with Iron Deficiency
    2023 120 citations Robert J. Mentz, Jyotsna Garg et al. profile →
  24. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
    2023 115 citations Stephen J. Greene, Justin A. Ezekowitz et al. Journal of the American College of Cardiology profile →
  25. Global epidemiology of heart failure
    2024 110 citations Marco Metra, Javed Butler et al. profile →
  26. Iron deficiency and cardiovascular disease
    2022 108 citations Javed Butler, Piotr Ponikowski et al. European Heart Journal profile →
  27. Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
    2023 107 citations Javed Butler, Gregg C. Fonarow et al. JAMA Cardiology profile →
  28. SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
    2023 75 citations Khawaja M. Talha, Stefan D. Anker et al. PubMed profile →
  29. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
    2024 70 citations Thomas M. Maddox, James L. Januzzi et al. Journal of the American College of Cardiology profile →
  30. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
    2023 67 citations Piotr Ponikowski, Robert J. Mentz et al. European Heart Journal profile →
  31. Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021
    2024 47 citations Ahmed Sayed, Dmitry Abramov et al. JAMA Cardiology profile →
  32. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
    2024 45 citations Muhammad Usman, Stefan D. Anker et al. profile →
  33. Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials
    2024 43 citations Barry A. Borlaug, Javed Butler et al. European Heart Journal profile →
  34. Inflammation in Obesity-Related HFpEF
    2024 41 citations Subodh Verma, Mark C. Petrie et al. Journal of the American College of Cardiology profile →
  35. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
    2025 13 citations Stefan D. Anker, Robert J. Mentz et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Javed Butler 29.1k 8.1k 6.4k 6.2k 4.5k 825 42.1k
Gerasimos Filippatos 30.8k 1.1× 7.9k 1.0× 6.3k 1.0× 7.5k 1.2× 5.0k 1.1× 625 43.8k
Adriaan A. Voors 28.3k 1.0× 5.7k 0.7× 5.6k 0.9× 7.2k 1.2× 5.1k 1.1× 688 41.4k
Aldo P. Maggioni 35.8k 1.2× 9.5k 1.2× 8.0k 1.2× 5.4k 0.9× 4.3k 1.0× 873 49.2k
Piotr Ponikowski 30.2k 1.0× 6.4k 0.8× 4.7k 0.7× 6.8k 1.1× 4.4k 1.0× 799 44.7k
Karl Swedberg 53.2k 1.8× 9.6k 1.2× 5.9k 0.9× 8.7k 1.4× 4.1k 0.9× 507 64.0k
Christian Torp‐Pedersen 32.3k 1.1× 5.8k 0.7× 7.4k 1.1× 4.3k 0.7× 3.3k 0.7× 1.3k 52.4k
Adrian F. Hernandez 26.2k 0.9× 6.5k 0.8× 6.3k 1.0× 5.4k 0.9× 3.0k 0.7× 899 42.2k
Milton Packer 52.9k 1.8× 10.6k 1.3× 9.4k 1.5× 8.5k 1.4× 7.3k 1.6× 655 65.6k
Henry Krum 27.8k 1.0× 6.8k 0.8× 5.5k 0.9× 4.7k 0.8× 4.0k 0.9× 566 36.9k
Lars Køber 39.2k 1.3× 10.1k 1.2× 10.5k 1.6× 5.6k 0.9× 6.0k 1.3× 1.4k 59.4k

Countries citing papers authored by Javed Butler

Since Specialization
Citations

This map shows the geographic impact of Javed Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javed Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javed Butler more than expected).

Fields of papers citing papers by Javed Butler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javed Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javed Butler. The network helps show where Javed Butler may publish in the future.

Co-authorship network of co-authors of Javed Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Javed Butler. A scholar is included among the top collaborators of Javed Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javed Butler. Javed Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, João Pedro, Pedro Marques, Stefan D. Anker, et al.. (2025). Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials. Diabetes Obesity and Metabolism. 28(2). 1105–1115.
2.
Sattar, Naveed, Javed Butler, Matthew M.Y. Lee, et al.. (2024). Body Mass Index and Cardiorenal Outcomes in the EMPEROR-Preserved Trial: Principal Findings and Meta-Analysis with the DELIVER Trial. European Journal of Heart Failure. 26(4). 900–909. 15 indexed citations
3.
Sayed, Ahmed, Dmitry Abramov, Gregg C. Fonarow, et al.. (2024). Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021. JAMA Cardiology. 9(6). 585–585. 47 indexed citations breakdown →
4.
Butler, Javed, Robert J. Mentz, & Adrian F. Hernandez. (2024). Iron Replacement Therapy in Heart Failure: Contextualizing the Results of the HEART-FID Trial. European Journal of Heart Failure. 26(3). 537–539. 1 indexed citations
5.
6.
Usman, Muhammad, James L. Januzzi, Stefan D. Anker, et al.. (2024). The Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Left Cardiac Remodelling in Heart Failure with Reduced Ejection Fraction: Systematic Review and Meta-Analysis. European Journal of Heart Failure. 26(2). 373–382. 16 indexed citations
7.
Bertero, Edoardo, Luca Carmisciano, Christian Jonasson, et al.. (2024). Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies. European Journal of Preventive Cardiology. 31(11). 1400–1407. 6 indexed citations
8.
Talha, Khawaja M., Jennifer Green, Gerasimos Filippatos, et al.. (2024). Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis. Diabetes Obesity and Metabolism. 26(7). 2578–2587. 3 indexed citations
9.
Ferreira, João Pedro, Javed Butler, Bettina J. Kraus, et al.. (2024). Early Changes in Estimated Glomerular Filtration Rate Post-Initiation of Empagliflozin in EMPEROR-Preserved. European Journal of Heart Failure. 26(4). 885–896. 10 indexed citations
10.
Verma, Subodh, Mark C. Petrie, Barry A. Borlaug, et al.. (2024). Inflammation in Obesity-Related HFpEF. Journal of the American College of Cardiology. 84(17). 1646–1662. 41 indexed citations breakdown →
11.
Siddiqi, Tariq Jamal, Harriette G.C. Van Spall, Stephen J. Greene, et al.. (2024). Role of telemedicine in the management of obesity: State‐of‐the‐art review. Obesity Reviews. 25(6). e13734–e13734. 5 indexed citations
12.
Talha, Khawaja M., Stephen J. Greene, Javed Butler, & Muhammad Shahzeb Khan. (2024). Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction. Heart Failure Clinics. 20(4). 387–398. 1 indexed citations
13.
Verma, Subodh, Javed Butler, Barry A. Borlaug, et al.. (2024). Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 84(17). 1603–1614. 17 indexed citations
14.
15.
Talha, Khawaja M., Stefan D. Anker, & Javed Butler. (2023). SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. PubMed. 5(2). 82–82. 75 indexed citations breakdown →
16.
Ferreira, João Pedro, Milton Packer, Javed Butler, et al.. (2023). Growth Differentiation Factor-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program. European Journal of Heart Failure. 26(1). 155–164. 11 indexed citations
17.
Zannad, Faı̈ez, João Pedro Ferreira, Stuart Pocock, et al.. (2020). Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function. Circulation. 143(4). 310–321. 180 indexed citations
18.
Adams, Kirkwood F., Jalal K. Ghali, J. Herbert Patterson, et al.. (2014). A Perspective on Re-Evaluating Digoxin's Role in the Current Management of Patients with Chronic Systolic Heart Failure: Targeting Serum Concentration to Reduce Hospitalization and Improve Safety Profile. European Journal of Heart Failure. 16(5). 483–493. 18 indexed citations
19.
Heidenreich, Paul A., Nancy M. Albert, Larry A. Allen, et al.. (2013). Forecasting the Impact of Heart Failure in the United States. Circulation Heart Failure. 6(3). 606–619. 2070 indexed citations breakdown →
20.
Felker, G. Michael, Vic Hasselblad, W.H. Wilson Tang, et al.. (2012). Troponin I in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Study. European Journal of Heart Failure. 14(11). 1257–1264. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerasimos Filippatos Breakdown of academic impact, for papers by Adriaan A. Voors Breakdown of academic impact, for papers by Aldo P. Maggioni Breakdown of academic impact, for papers by Piotr Ponikowski Breakdown of academic impact, for papers by Karl Swedberg Breakdown of academic impact, for papers by Christian Torp‐Pedersen Breakdown of academic impact, for papers by Adrian F. Hernandez Breakdown of academic impact, for papers by Milton Packer Breakdown of academic impact, for papers by Henry Krum Breakdown of academic impact, for papers by Lars Køber
Rankless by CCL
2026